| Financial Year |
March 31 2023 |
| Monetary Funds |
1,299,925,470.54 |
| Held-for-trading Financial Assets |
445,494,703.79 |
| Notes Receivable |
971,585.00 |
| Accounts Receivable |
407,521,567.15 |
| Advances to Suppliers |
129,483,657.00 |
| Other Receivables |
12,399,373.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
774,593,112.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
150,052,387.52 |
| Total Current Assets |
3,257,564,800.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
182,408,453.04 |
| Investment Properties |
-- |
| Fixed Assetes |
828,289,451.61 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,739,894.96 |
| R&D expenses |
666,000.90 |
| Goodwill |
10,552,673.08 |
| Long-Term Deferred and Prepaid Expenses |
40,112,605.67 |
| Deferred Income Tax Assets |
106,663,781.09 |
| Other Non-Current Assets |
5,982,394.00 |
| Sub-Total of Non-Current Assets |
1,391,282,274.71 |
| Total Assets |
4,648,847,075.64 |
| Short-Term Loans |
39,853,232.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,920,323.05 |
| Accounts Payable |
395,957,884.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,683,472.81 |
| Taxes Payable |
52,615,486.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,264,771.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,532,525.23 |
| Other Current Liabilities |
20,237,872.92 |
| Sub-Total of Current Liabilities |
765,141,705.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
67,663,242.24 |
| Deferred Income Tax Liabilities |
21,236,879.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
231,737,366.33 |
| Total Liabilities |
996,879,072.19 |
| Paid-In Capital(Or Share Stock) |
233,993,066.00 |
| Capital Surplus |
1,911,525,894.33 |
| Surplus Reserve |
125,726,256.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,308,217,079.14 |
| Minority Stockholder's Interest |
79,824,252.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,572,143,750.74 |
| Owner's Equity（Stockholder's Equity） |
3,651,968,003.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,648,847,075.64 |
